The third and final stage of clinical trial of a COVID-19 vaccine being developed by Oxford University and Astrazeneca has been put on hold temporarily. In a statement, the British manufacturing company said, it was a routine pause in the case of an unexplained illness.<br />”&nbsp;<br />”<span style="color: #222222;">It has further stated that the temporarily pause in vaccination is to allow review of vaccine safety by an independent committee. The Oxford vaccine is one of the major candidate vaccine being developed in the fight against COVID-19.</span><br />